Patrik Tigerschiöld proposed as new Board Chairman

– Vice President Henrik Blomquist to become Acting CEO.

The information contained herein is subject to the disclosure requirements of
Bure Equity AB under the Swedish Securities Market Act. The information has been
publicly communicated on 4 April 2013, 10:00 a.m. CET.

The nominating committee of Bure Equity proposes that the company’s current CEO
Patrik Tigerschiöld be appointed as Board Chairman. At the same time, Bure’s
Vice President Henrik Blomquist is proposed as Acting CEO.
The current Board Chairman Björn Björnsson, who has been Chairman since 2010 and
a member of the Board since 2002, has declined re-election.

”The nominating committee’s assessment is that this is the best possible
solution to safeguard the company’s business and continuity. Patrik is Chairman
of Bure’s portfolio companies Micronic Mydata, PartnerTech and Vitrolife,” says
Lars Olofsson, chairman of Bure’s nominating committee.

Patrik Tigerschiöld has been CEO of Bure since 2010 and was previously Board
Chairman during the period 2004-2009. Patrik was CEO of Skanditek during 1999
-2010.

Provided that the Annual General Meeting on 22 April approves the nominating
committee’s proposal, it is the Board’s intention to appoint the company’s Vice
President Henrik Blomquist as Acting CEO. He has worked for Bure since 2010 and
was previously active as an investment manager at Skanditek since 1999. Henrik
is 42 years old and holds an M. Sc. in Economics from Stockholm University.

The nominating committee’s complete proposals and motivating statement are
available on the company’s website, www.bure.se.

Bure Equity AB (publ)

For more information contact:

Patrik Tigerschiöld, CEO, Tel. +46 8– 614 00 20

Bure is a listed investment company with ownership interests in Nordic
companies. The current holdings consist of seven portfolio companies, of which
four are listed.